Headache . 2025 Dec 19. doi: 10.1111/head.70000. Online ahead of print. Benoit Gerard , Hubert Praudel , Michel Lanteri-Minet , Elise Van Obberghen , Fanny Rocher-Moreau , Johanna Rousset , Ulysse Jacquier , Sylvie Leroy , Margot Delin Abstract Background: Eptinezumab is an anti-calcitonin gene-related peptide monoclonal antibody used for
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans
Neurology and therapy 2025 Dec 18. doi: 10.1007/s40120-025-00874-z. Online ahead of print. Peter J Goadsby , Alexandra J Sinclair , Shazia K Afridi , Christian Lucas , Jerôme Mawet , Michel Lanteri-Minet , Xavier Moisset , Hans Christoph Diener , Charly Gaul , Tim Patrick Jürgens , Marja-Liisa Sumelahti , Margarita Sanchez
Trends in the real-world management of cluster headache patients treated by subcutaneous sumatriptan and/or oxygen in France – An analysis of the French National Social Security System Open Data over eleven years (2014-2024)
Revue Neurologique (Paris) . 2025 Dec 16:S0035-3787(25)00653-8. doi: 10.1016/j.neurol.2025.11.004. Online ahead of print. E K Van Obberghen , R Fabre, L Bailly , M Lanteri-Minet Abstract The burden of cluster headache (CH) requires better knowledge of management to improve it. Objectives: To describe changes in
Cluster headache suicidality: a systematic review with a meta-analysis
The Journal of Headache and Pain . 2025 Dec 4;26(1):281. doi: 10.1186/s10194-025-02140-x. E K Van Obberghen , R Fabre , M Lanteri-Minet Abstract Background: Suicide is considered as common in patients with cluster headache (CH) and is defined as ‘suicidal headache’. However, the exact